1 Min Read
Sept 1 (Reuters) - Moberg Pharma Ab (Publ):
* PATENT IS EXPECTED TO PROVIDE COVERAGE THROUGH AT LEAST 2032 Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.